Biovie (BIVI) Shares Issued (2020 - 2026)
Biovie (BIVI) posted Shares Issued of $2.8 million for Q1 2026, up 4315.11% sequentially from $63087.0 in Q4 2025, and up 521.08% YoY from $448470.0 in Q1 2025.
Biovie (BIVI) Shares Issued (2020 - 2026) Analysis & Trends
Biovie has reported Shares Issued for 7 years, with the latest figure at $2.8 million in Q1 2026.
- Quarterly Shares Issued rose 521.08% year-over-year to $2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 million (up 521.08% YoY) and the FY2025 annual result came in at $84872.0, up 63.82% from the prior year.
- Shares Issued rose to $2.8 million in Q1 2026 per BIVI's latest filing, from $63087.0 in the prior quarter.
- Over five years, Shares Issued peaked at $2.8 million in Q1 2026 and troughed at $12452.0 in Q2 2022.
- A 5-year average of $564342.8 and a median of $429228.5 in 2024 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2022 and 2026: Shares Issued slumped 98.35% in 2022, then jumped 521.08% in 2026.
- Over 5 years, Shares Issued stood at $1.0 million in 2022, then slumped by 31.86% to $687428.0 in 2023, then sank by 40.36% to $409987.0 in 2024, then slumped by 84.61% to $63087.0 in 2025, then soared by 4315.11% to $2.8 million in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $2.8 million, $63087.0, and $55022.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Biovie | 14.17 Mn | 14.17 Mn | - | 7.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.79 Mn |
| Jun 30, 2026 | 2.79 Mn |
| Mar 31, 2026 | 2.79 Mn |
| Mar 31, 2026 | 2.79 Mn |
| Dec 31, 2025 | 63,087.00 |
| Dec 31, 2025 | 63,087.00 |
| Sep 30, 2025 | 55,022.00 |
| Sep 30, 2025 | 55,022.00 |
| Jun 30, 2025 | 84,872.00 |
| Jun 30, 2025 | 84,872.00 |
| Mar 31, 2025 | 448,470.00 |
| Mar 31, 2025 | 448,470.00 |
| Dec 31, 2024 | 409,987.00 |
| Dec 31, 2024 | 409,987.00 |
| Sep 30, 2024 | 35,723.00 |
| Sep 30, 2024 | 35,723.00 |
| Jun 30, 2024 | 51,808.00 |
| Jun 30, 2024 | 51,808.00 |
| Mar 31, 2024 | 539,920.00 |
| Mar 31, 2024 | 539,920.00 |